Literature DB >> 28966417

Latent Class Survival Models Linked by Principal Stratification to Investigate Heterogenous Survival Subgroups Among Individuals With Early-Stage Kidney Cancer.

Brian L Egleston1, Robert G Uzzo1, Yu-Ning Wong2.   

Abstract

Rates of kidney cancer have been increasing, with small incidental tumors experiencing the fastest growth rates. Much of the increase could be due to increased use of CT scans, MRIs, and ultrasounds for unrelated conditions. Many tumors might never have been detected or become symptomatic in the past. This suggests that many patients might benefit from less aggressive therapy, such as active surveillance by which tumors are surgically removed only if they become sufficiently large. However, it has been difficult for clinicians to identify subgroups of patients for whom treatment might be especially beneficial or harmful. In this work, we use a principal stratification framework to estimate the proportion and characteristics of individuals who have large or small hazard rates of death in two treatment arms. This allows us to assess who might be helped or harmed by aggressive treatment. We also use Weibull mixture models. This work differs from much previous work in that the survival classes upon which principal stratification is based are latent variables. That is, survival class is not an observed variable. We apply this work using Surveillance Epidemiology and End Results-Medicare claims data. Clinicians can use our methods for investigating treatments with heterogeneous effects.

Entities:  

Year:  2016        PMID: 28966417      PMCID: PMC5615848          DOI: 10.1080/01621459.2016.1240078

Source DB:  PubMed          Journal:  J Am Stat Assoc        ISSN: 0162-1459            Impact factor:   5.033


  35 in total

1.  Principal stratification in causal inference.

Authors:  Constantine E Frangakis; Donald B Rubin
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

2.  General growth mixture modeling for randomized preventive interventions.

Authors:  Bengt Muthén; C Hendricks Brown; Katherine Masyn; Booil Jo; Siek-Toon Khoo; Chih-Chien Yang; Chen-Pin Wang; Sheppard G Kellam; John B Carlin; Jason Liao
Journal:  Biostatistics       Date:  2002-12       Impact factor: 5.899

3.  An estimator for treatment comparisons among survivors in randomized trials.

Authors:  Douglas Hayden; Donna K Pauler; David Schoenfeld
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

4.  A tutorial on principal stratification-based sensitivity analysis: application to smoking cessation studies.

Authors:  Brian L Egleston; Karen L Cropsey; Amy B Lazev; Carolyn J Heckman
Journal:  Clin Trials       Date:  2010-04-27       Impact factor: 2.486

5.  Rising incidence of small renal masses: a need to reassess treatment effect.

Authors:  John M Hollingsworth; David C Miller; Stephanie Daignault; Brent K Hollenbeck
Journal:  J Natl Cancer Inst       Date:  2006-09-20       Impact factor: 13.506

6.  Causal inference in longitudinal comparative effectiveness studies with repeated measures of a continuous intermediate variable.

Authors:  Chen-Pin Wang; Booil Jo; C Hendricks Brown
Journal:  Stat Med       Date:  2014-02-27       Impact factor: 2.373

7.  On the use of propensity scores in principal causal effect estimation.

Authors:  Booil Jo; Elizabeth A Stuart
Journal:  Stat Med       Date:  2009-10-15       Impact factor: 2.373

8.  Estimating drug effects in the presence of placebo response: causal inference using growth mixture modeling.

Authors:  Bengt Muthén; Hendricks C Brown
Journal:  Stat Med       Date:  2009-11-30       Impact factor: 2.373

9.  Sensitivity Analyses Comparing Time-to-Event Outcomes Existing Only in a Subset Selected Postrandomization.

Authors:  Bryan E Shepherd; Peter B Gilbert; Thomas Lumley
Journal:  J Am Stat Assoc       Date:  2007-06       Impact factor: 5.033

10.  Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary Intervention.

Authors:  Nihar R Desai; Steven M Bradley; Craig S Parzynski; Brahmajee K Nallamothu; Paul S Chan; John A Spertus; Manesh R Patel; Jeremy Ader; Aaron Soufer; Harlan M Krumholz; Jeptha P Curtis
Journal:  JAMA       Date:  2015-11-17       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.